|  Help  |  About  |  Contact Us

Search our database by keyword

- or -

Examples

  • Search this entire website. Enter identifiers, names or keywords for genes, diseases, strains, ontology terms, etc. (e.g. Pax6, Parkinson, ataxia)
  • Use OR to search for either of two terms (e.g. OR mus) or quotation marks to search for phrases (e.g. "dna binding").
  • Boolean search syntax is supported: e.g. Balb* for partial matches or mus AND NOT embryo to exclude a term

Search results 1 to 100 out of 371 for Ctla4

Category restricted to Publication (x)

<< First    < Previous  |  Next >    Last >>
0.042s

Categories

Category: Publication
Type Details Score
Publication
First Author: Zheng P
Year: 1998
Journal: Proc Natl Acad Sci U S A
Title: B7-CTLA4 interaction enhances both production of antitumor cytotoxic T lymphocytes and resistance to tumor challenge.
Volume: 95
Issue: 11
Pages: 6284-9
Publication
First Author: Ostrov DA
Year: 2000
Journal: Science
Title: Structure of murine CTLA-4 and its role in modulating T cell responsiveness.
Volume: 290
Issue: 5492
Pages: 816-9
Publication
First Author: Greenwald RJ
Year: 2002
Journal: Eur J Immunol
Title: CTLA-4 regulates cell cycle progression during a primary immune response.
Volume: 32
Issue: 2
Pages: 366-73
Publication
First Author: Du X
Year: 2018
Journal: Cell Res
Title: Uncoupling therapeutic from immunotherapy-related adverse effects for safer and effective anti-CTLA-4 antibodies in CTLA4 humanized mice.
Volume: 28
Issue: 4
Pages: 433-447
Publication
First Author: Lute KD
Year: 2005
Journal: Blood
Title: Human CTLA4 knock-in mice unravel the quantitative link between tumor immunity and autoimmunity induced by anti-CTLA-4 antibodies.
Volume: 106
Issue: 9
Pages: 3127-33
Publication
First Author: Schubert D
Year: 2014
Journal: Nat Med
Title: Autosomal dominant immune dysregulation syndrome in humans with CTLA4 mutations.
Volume: 20
Issue: 12
Pages: 1410-1416
Publication
First Author: Lundholm M
Year: 2006
Journal: Diabetes
Title: Defective induction of CTLA-4 in the NOD mouse is controlled by the NOD allele of Idd3/IL-2 and a novel locus (Ctex) telomeric on chromosome 1.
Volume: 55
Issue: 2
Pages: 538-44
Publication
First Author: Ueda H
Year: 2003
Journal: Nature
Title: Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease.
Volume: 423
Issue: 6939
Pages: 506-11
Publication  
First Author: Poels K
Year: 2020
Journal: Cells
Title: Antibody-Mediated Inhibition of CTLA4 Aggravates Atherosclerotic Plaque Inflammation and Progression in Hyperlipidemic Mice.
Volume: 9
Issue: 9
Publication
First Author: Mao Y
Year: 2004
Journal: Exp Hematol
Title: Overexpression of a mutant CTLA4 inhibits T-cell activation and homeostasis-driven expansion.
Volume: 32
Issue: 8
Pages: 735-47
Publication
First Author: Freeman GJ
Year: 1993
Journal: J Exp Med
Title: Murine B7-2, an alternative CTLA4 counter-receptor that costimulates T cell proliferation and interleukin 2 production.
Volume: 178
Issue: 6
Pages: 2185-92
Publication
First Author: Miska J
Year: 2018
Journal: J Exp Med
Title: Initiation of inflammatory tumorigenesis by CTLA4 insufficiency due to type 2 cytokines.
Volume: 215
Issue: 3
Pages: 841-858
Publication
First Author: Tang AL
Year: 2008
Journal: J Immunol
Title: CTLA4 expression is an indicator and regulator of steady-state CD4+ FoxP3+ T cell homeostasis.
Volume: 181
Issue: 3
Pages: 1806-13
Publication
First Author: Ling V
Year: 1999
Journal: Genomics
Title: Complete sequence determination of the mouse and human CTLA4 gene loci: cross-species DNA sequence similarity beyond exon borders.
Volume: 60
Issue: 3
Pages: 341-55
Publication
First Author: Linsley PS
Year: 1991
Journal: J Exp Med
Title: CTLA-4 is a second receptor for the B cell activation antigen B7.
Volume: 174
Issue: 3
Pages: 561-9
Publication
First Author: Wang XB
Year: 2002
Journal: Scand J Immunol
Title: Expression of CTLA-4 by human monocytes.
Volume: 55
Issue: 1
Pages: 53-60
Publication
First Author: Dovedi SJ
Year: 2021
Journal: Cancer Discov
Title: Design and Efficacy of a Monovalent Bispecific PD-1/CTLA4 Antibody That Enhances CTLA4 Blockade on PD-1+ Activated T Cells.
Volume: 11
Issue: 5
Pages: 1100-1117
Publication
First Author: Lane P
Year: 1993
Journal: Immunology
Title: Expression and functional properties of mouse B7/BB1 using a fusion protein between mouse CTLA4 and human gamma 1.
Volume: 80
Issue: 1
Pages: 56-61
Publication
First Author: Wicker LS
Year: 2004
Journal: J Immunol
Title: Fine mapping, gene content, comparative sequencing, and expression analyses support Ctla4 and Nramp1 as candidates for Idd5.1 and Idd5.2 in the nonobese diabetic mouse.
Volume: 173
Issue: 1
Pages: 164-73
Publication      
First Author: Zhong X
Year: 2018
Journal: MGI Direct Data Submission
Title: Mutagenetix entry for complementary.
Publication
First Author: Brayer J
Year: 2000
Journal: J Rheumatol
Title: Alleles from chromosomes 1 and 3 of NOD mice combine to influence Sjögren's syndrome-like autoimmune exocrinopathy.
Volume: 27
Issue: 8
Pages: 1896-904
Publication
First Author: Chen Z
Year: 2006
Journal: Proc Natl Acad Sci U S A
Title: Modeling CTLA4-linked autoimmunity with RNA interference in mice.
Volume: 103
Issue: 44
Pages: 16400-5
Publication
First Author: Do P
Year: 2019
Journal: J Immunol
Title: Leukemic B Cell CTLA-4 Suppresses Costimulation of T Cells.
Volume: 202
Issue: 9
Pages: 2806-2816
Publication
First Author: Turnbull C
Year: 2023
Journal: Sci Adv
Title: DECTIN-1: A modifier protein in CTLA-4 haploinsufficiency.
Volume: 9
Issue: 49
Pages: eadi9566
Publication
First Author: Bailey C
Year: 2023
Journal: Cell Rep Med
Title: Genetic and pharmaceutical targeting of HIF1α allows combo-immunotherapy to boost graft vs. leukemia without exacerbation graft vs. host disease.
Volume: 4
Issue: 11
Pages: 101236
Publication
First Author: Hunter K
Year: 2007
Journal: J Immunol
Title: Interactions between Idd5.1/Ctla4 and other type 1 diabetes genes.
Volume: 179
Issue: 12
Pages: 8341-9
Publication
First Author: Jakubczik F
Year: 2016
Journal: Diabetes
Title: A SNP in the Immunoregulatory Molecule CTLA-4 Controls mRNA Splicing In Vivo but Does Not Alter Diabetes Susceptibility in the NOD Mouse.
Volume: 65
Issue: 1
Pages: 120-8
Publication
First Author: Araki M
Year: 2009
Journal: J Immunol
Title: Genetic evidence that the differential expression of the ligand-independent isoform of CTLA-4 is the molecular basis of the Idd5.1 type 1 diabetes region in nonobese diabetic mice.
Volume: 183
Issue: 8
Pages: 5146-57
Publication
First Author: Vaughan AN
Year: 2000
Journal: J Immunol
Title: Porcine CTLA4-Ig lacks a MYPPPY motif, binds inefficiently to human B7 and specifically suppresses human CD4+ T cell responses costimulated by pig but not human B7.
Volume: 165
Issue: 6
Pages: 3175-81
Publication
First Author: Gerold KD
Year: 2011
Journal: Diabetes
Title: The soluble CTLA-4 splice variant protects from type 1 diabetes and potentiates regulatory T-cell function.
Volume: 60
Issue: 7
Pages: 1955-63
Publication
First Author: Wei SC
Year: 2021
Journal: Cancer Discov
Title: A Genetic Mouse Model Recapitulates Immune Checkpoint Inhibitor-Associated Myocarditis and Supports a Mechanism-Based Therapeutic Intervention.
Volume: 11
Issue: 3
Pages: 614-625
Publication
First Author: Noyes H
Year: 2015
Journal: Parasitology
Title: Evidence for genes controlling resistance to Heligmosomoides bakeri on mouse chromosome 1.
Volume: 142
Issue: 4
Pages: 566-75
Publication
First Author: Ichinose K
Year: 2013
Journal: Arthritis Rheum
Title: Brief report: increased expression of a short splice variant of CTLA-4 exacerbates lupus in MRL/lpr mice.
Volume: 65
Issue: 3
Pages: 764-9
Publication
First Author: Miska J
Year: 2012
Journal: Eur J Immunol
Title: Autoimmunity-mediated antitumor immunity: tumor as an immunoprivileged self.
Volume: 42
Issue: 10
Pages: 2584-96
Publication
First Author: Fargeas CA
Year: 1995
Journal: J Exp Med
Title: Identification of residues in the V domain of CD80 (B7-1) implicated in functional interactions with CD28 and CTLA4.
Volume: 182
Issue: 3
Pages: 667-75
Publication
First Author: Ma P
Year: 2024
Journal: Circulation
Title: Expansion of Pathogenic Cardiac Macrophages in Immune Checkpoint Inhibitor Myocarditis.
Volume: 149
Issue: 1
Pages: 48-66
Publication
First Author: Liu SM
Year: 2012
Journal: J Immunol
Title: Overexpression of the Ctla-4 isoform lacking exons 2 and 3 causes autoimmunity.
Volume: 188
Issue: 1
Pages: 155-62
Publication
First Author: Blazar BR
Year: 1994
Journal: Blood
Title: In vivo blockade of CD28/CTLA4: B7/BB1 interaction with CTLA4-Ig reduces lethal murine graft-versus-host disease across the major histocompatibility complex barrier in mice.
Volume: 83
Issue: 12
Pages: 3815-25
Publication
First Author: Lamhamedi-Cherradi SE
Year: 2001
Journal: Diabetes
Title: Further mapping of the Idd5.1 locus for autoimmune diabetes in NOD mice.
Volume: 50
Issue: 12
Pages: 2874-8
Publication
First Author: Paterson AM
Year: 2015
Journal: J Exp Med
Title: Deletion of CTLA-4 on regulatory T cells during adulthood leads to resistance to autoimmunity.
Volume: 212
Issue: 10
Pages: 1603-21
Publication
First Author: Alissafi T
Year: 2017
Journal: J Clin Invest
Title: Tregs restrain dendritic cell autophagy to ameliorate autoimmunity.
Volume: 127
Issue: 7
Pages: 2789-2804
Publication
First Author: Brunet JF
Year: 1987
Journal: Nature
Title: A new member of the immunoglobulin superfamily--CTLA-4.
Volume: 328
Issue: 6127
Pages: 267-70
Publication
First Author: Schwartz JC
Year: 2001
Journal: Nature
Title: Structural basis for co-stimulation by the human CTLA-4/B7-2 complex.
Volume: 410
Issue: 6828
Pages: 604-8
Publication
First Author: Luhder F
Year: 2000
Journal: Proc Natl Acad Sci U S A
Title: Pinpointing when T cell costimulatory receptor CTLA-4 must be engaged to dampen diabetogenic T cells.
Volume: 97
Issue: 22
Pages: 12204-9
Publication
First Author: Tivol EA
Year: 1995
Journal: Immunity
Title: Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4.
Volume: 3
Issue: 5
Pages: 541-7
Publication
First Author: Schneider H
Year: 2006
Journal: Science
Title: Reversal of the TCR stop signal by CTLA-4.
Volume: 313
Issue: 5795
Pages: 1972-5
Publication
First Author: Tang Q
Year: 2004
Journal: Eur J Immunol
Title: Distinct roles of CTLA-4 and TGF-beta in CD4+CD25+ regulatory T cell function.
Volume: 34
Issue: 11
Pages: 2996-3005
Publication
First Author: Tivol EA
Year: 1997
Journal: J Immunol
Title: CTLA4Ig prevents lymphoproliferation and fatal multiorgan tissue destruction in CTLA-4-deficient mice.
Volume: 158
Issue: 11
Pages: 5091-4
Publication
First Author: Tai X
Year: 2012
Journal: Blood
Title: Basis of CTLA-4 function in regulatory and conventional CD4(+) T cells.
Volume: 119
Issue: 22
Pages: 5155-63
Publication
First Author: Schmidt EM
Year: 2009
Journal: J Immunol
Title: Ctla-4 controls regulatory T cell peripheral homeostasis and is required for suppression of pancreatic islet autoimmunity.
Volume: 182
Issue: 1
Pages: 274-82
Publication
First Author: Khattri R
Year: 1999
Journal: J Immunol
Title: Lymphoproliferative disorder in CTLA-4 knockout mice is characterized by CD28-regulated activation of Th2 responses.
Volume: 162
Issue: 10
Pages: 5784-91
Publication
First Author: Wang CJ
Year: 2012
Journal: J Immunol
Title: Cutting edge: cell-extrinsic immune regulation by CTLA-4 expressed on conventional T cells.
Volume: 189
Issue: 3
Pages: 1118-22
Publication
First Author: Tivol EA
Year: 2002
Journal: J Immunol
Title: Re-establishing peripheral tolerance in the absence of CTLA-4: complementation by wild-type T cells points to an indirect role for CTLA-4.
Volume: 169
Issue: 4
Pages: 1852-8
Publication
First Author: Verhagen J
Year: 2013
Journal: Proc Natl Acad Sci U S A
Title: CTLA-4 controls the thymic development of both conventional and regulatory T cells through modulation of the TCR repertoire.
Volume: 110
Issue: 3
Pages: E221-30
Publication
First Author: Waterhouse P
Year: 1995
Journal: Science
Title: Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4.
Volume: 270
Issue: 5238
Pages: 985-8
Publication
First Author: Waterhouse P
Year: 1997
Journal: Eur J Immunol
Title: Normal thymic selection, normal viability and decreased lymphoproliferation in T cell receptor-transgenic CTLA-4-deficient mice.
Volume: 27
Issue: 8
Pages: 1887-92
Publication
First Author: Frauwirth KA
Year: 2001
Journal: J Immunol
Title: CTLA-4 is not required for induction of CD8(+) T cell anergy in vivo.
Volume: 167
Issue: 9
Pages: 4936-41
Publication
First Author: Kwon H
Year: 2004
Journal: J Immunol
Title: Role of CTLA-4 in the activation of single- and double-positive thymocytes.
Volume: 173
Issue: 11
Pages: 6645-53
Publication
First Author: Katz G
Year: 2014
Journal: Sci Signal
Title: T cell receptor stimulation impairs IL-7 receptor signaling by inducing expression of the microRNA miR-17 to target Janus kinase 1.
Volume: 7
Issue: 340
Pages: ra83
Publication
First Author: Harlin H
Year: 2002
Journal: Eur J Immunol
Title: CTLA-4 engagement regulates NF-kappaB activation in vivo.
Volume: 32
Issue: 8
Pages: 2095-104
Publication
First Author: Gajewski TF
Year: 2001
Journal: J Immunol
Title: Absence of CTLA-4 lowers the activation threshold of primed CD8+ TCR-transgenic T cells: lack of correlation with Src homology domain 2-containing protein tyrosine phosphatase.
Volume: 166
Issue: 6
Pages: 3900-7
Publication
First Author: Chambers CA
Year: 1997
Journal: Proc Natl Acad Sci U S A
Title: Thymocyte development is normal in CTLA-4-deficient mice.
Volume: 94
Issue: 17
Pages: 9296-301
Publication
First Author: Pandiyan P
Year: 2007
Journal: J Immunol
Title: High IFN-gamma production of individual CD8 T lymphocytes is controlled by CD152 (CTLA-4).
Volume: 178
Issue: 4
Pages: 2132-40
Publication
First Author: Chambers CA
Year: 1998
Journal: Eur J Immunol
Title: Secondary but not primary T cell responses are enhanced in CTLA-4-deficient CD8+ T cells.
Volume: 28
Issue: 10
Pages: 3137-43
Publication
First Author: Chambers CA
Year: 2002
Journal: Blood
Title: The lymphoproliferative defect in CTLA-4-deficient mice is ameliorated by an inhibitory NK cell receptor.
Volume: 99
Issue: 12
Pages: 4509-16
Publication
First Author: Inobe M
Year: 2004
Journal: J Immunol
Title: CTLA-4 engagement acts as a brake on CD4+ T cell proliferation and cytokine production but is not required for tuning T cell reactivity in adaptive tolerance.
Volume: 173
Issue: 12
Pages: 7239-48
Publication
First Author: Pandiyan P
Year: 2004
Journal: J Exp Med
Title: CD152 (CTLA-4) determines the unequal resistance of Th1 and Th2 cells against activation-induced cell death by a mechanism requiring PI3 kinase function.
Volume: 199
Issue: 6
Pages: 831-42
Publication
First Author: Sojka DK
Year: 2009
Journal: Eur J Immunol
Title: CTLA-4 is required by CD4+CD25+ Treg to control CD4+ T-cell lymphopenia-induced proliferation.
Volume: 39
Issue: 6
Pages: 1544-51
Publication
First Author: Quandt D
Year: 2007
Journal: J Immunol
Title: A new role of CTLA-4 on B cells in thymus-dependent immune responses in vivo.
Volume: 179
Issue: 11
Pages: 7316-24
Publication
First Author: Pedicord VA
Year: 2011
Journal: Proc Natl Acad Sci U S A
Title: Single dose of anti-CTLA-4 enhances CD8+ T-cell memory formation, function, and maintenance.
Volume: 108
Issue: 1
Pages: 266-71
Publication
First Author: Rudolph M
Year: 2011
Journal: J Immunol
Title: Blockade of CTLA-4 decreases the generation of multifunctional memory CD4+ T cells in vivo.
Volume: 186
Issue: 10
Pages: 5580-9
Publication
First Author: Knieke K
Year: 2012
Journal: PLoS One
Title: Migration of Th1 lymphocytes is regulated by CD152 (CTLA-4)-mediated signaling via PI3 kinase-dependent Akt activation.
Volume: 7
Issue: 3
Pages: e31391
Publication
First Author: Chambers CA
Year: 1997
Journal: Immunity
Title: Lymphoproliferation in CTLA-4-deficient mice is mediated by costimulation-dependent activation of CD4+ T cells.
Volume: 7
Issue: 6
Pages: 885-95
Publication
First Author: Ise W
Year: 2010
Journal: Nat Immunol
Title: CTLA-4 suppresses the pathogenicity of self antigen-specific T cells by cell-intrinsic and cell-extrinsic mechanisms.
Volume: 11
Issue: 2
Pages: 129-35
Publication
First Author: Walker LS
Year: 2002
Journal: J Immunol
Title: CTLA-4 differentially regulates T cell responses to endogenous tissue protein versus exogenous immunogen.
Volume: 169
Issue: 11
Pages: 6202-9
Publication
First Author: Muth S
Year: 2012
Journal: Proc Natl Acad Sci U S A
Title: Release of dendritic cells from cognate CD4+ T-cell recognition results in impaired peripheral tolerance and fatal cytotoxic T-cell mediated autoimmunity.
Volume: 109
Issue: 23
Pages: 9059-64
Publication
First Author: Akkaya B
Year: 2019
Journal: Nat Immunol
Title: Regulatory T cells mediate specific suppression by depleting peptide-MHC class II from dendritic cells.
Volume: 20
Issue: 2
Pages: 218-231
Publication
First Author: Klocke K
Year: 2016
Journal: Proc Natl Acad Sci U S A
Title: Induction of autoimmune disease by deletion of CTLA-4 in mice in adulthood.
Volume: 113
Issue: 17
Pages: E2383-92
Publication
First Author: Ohno K
Year: 1999
Journal: J Vet Med Sci
Title: Cloning of feline cDNA encoding the cytotoxic T lymphocyte-associated antigen 4 (CTLA-4).
Volume: 61
Issue: 11
Pages: 1241-4
Publication
First Author: Khatlani TS
Year: 2000
Journal: Immunogenetics
Title: Cloning and sequencing of dog cDNA encoding the T-cell costimulatory molecule (CTLA-4).
Volume: 51
Issue: 1
Pages: 79-81
Publication
First Author: Milich DR
Year: 1994
Journal: J Immunol
Title: Soluble CTLA-4 can suppress autoantibody production and elicit long term unresponsiveness in a novel transgenic model.
Volume: 153
Issue: 1
Pages: 429-35
Publication
First Author: Shiratori T
Year: 1997
Journal: Immunity
Title: Tyrosine phosphorylation controls internalization of CTLA-4 by regulating its interaction with clathrin-associated adaptor complex AP-2.
Volume: 6
Issue: 5
Pages: 583-9
Publication
First Author: Samoilova EB
Year: 1998
Journal: Int Immunol
Title: CTLA-4 is required for the induction of high dose oral tolerance.
Volume: 10
Issue: 4
Pages: 491-8
Publication
First Author: Schwartz JC
Year: 2002
Journal: Nat Immunol
Title: Structural mechanisms of costimulation.
Volume: 3
Issue: 5
Pages: 427-34
Publication
First Author: Yi LA
Year: 2004
Journal: Int Immunol
Title: Tyrosine-mediated inhibitory signals contribute to CTLA-4 function in vivo.
Volume: 16
Issue: 4
Pages: 539-47
Publication
First Author: Vijayakrishnan L
Year: 2004
Journal: Immunity
Title: An autoimmune disease-associated CTLA-4 splice variant lacking the B7 binding domain signals negatively in T cells.
Volume: 20
Issue: 5
Pages: 563-75
Publication
First Author: Eagar TN
Year: 2004
Journal: J Immunol
Title: CTLA-4 regulates expansion and differentiation of Th1 cells following induction of peripheral T cell tolerance.
Volume: 172
Issue: 12
Pages: 7442-50
Publication
First Author: Martins GA
Year: 2004
Journal: J Immunol
Title: CTLA-4 blockage increases resistance to infection with the intracellular protozoan Trypanosoma cruzi.
Volume: 172
Issue: 8
Pages: 4893-901
Publication
First Author: van Wijk F
Year: 2005
Journal: J Immunol
Title: CTLA-4 signaling regulates the intensity of hypersensitivity responses to food antigens, but is not decisive in the induction of sensitization.
Volume: 174
Issue: 1
Pages: 174-9
Publication
First Author: Treschow AP
Year: 2005
Journal: J Immunol
Title: Intrinsic tolerance in autologous collagen-induced arthritis is generated by CD152-dependent CD4+ suppressor cells.
Volume: 174
Issue: 11
Pages: 6742-50
Publication
First Author: Grohmann U
Year: 2002
Journal: Nat Immunol
Title: CTLA-4-Ig regulates tryptophan catabolism in vivo.
Volume: 3
Issue: 11
Pages: 1097-101
Publication
First Author: Liu Z
Year: 2001
Journal: J Immunol
Title: B7 interactions with CD28 and CTLA-4 control tolerance or induction of mucosal inflammation in chronic experimental colitis.
Volume: 167
Issue: 3
Pages: 1830-8
Publication
First Author: Fevery S
Year: 2007
Journal: Leukemia
Title: CTLA-4 blockade in murine bone marrow chimeras induces a host-derived antileukemic effect without graft-versus-host disease.
Volume: 21
Issue: 7
Pages: 1451-9
Publication
First Author: Dalai SK
Year: 2008
Journal: J Immunol
Title: Anergy in memory CD4+ T cells is induced by B cells.
Volume: 181
Issue: 5
Pages: 3221-31
Publication
First Author: Choi JM
Year: 2008
Journal: Proc Natl Acad Sci U S A
Title: Transduction of the cytoplasmic domain of CTLA-4 inhibits TcR-specific activation signals and prevents collagen-induced arthritis.
Volume: 105
Issue: 50
Pages: 19875-80
Publication
First Author: Catalfamo M
Year: 2008
Journal: Immunology
Title: TcR-induced regulated secretion leads to surface expression of CTLA-4 in CD4+CD25+ T cells.
Volume: 125
Issue: 1
Pages: 70-9
Publication
First Author: Jackman RP
Year: 2007
Journal: J Immunol
Title: CTLA-4 differentially regulates the immunological synapse in CD4 T cell subsets.
Volume: 178
Issue: 9
Pages: 5543-51
Publication
First Author: Feunou P
Year: 2007
Journal: J Immunol
Title: Foxp3+CD25+ T regulatory cells stimulate IFN-gamma-independent CD152-mediated activation of tryptophan catabolism that provides dendritic cells with immune regulatory activity in mice unresponsive to staphylococcal enterotoxin B.
Volume: 179
Issue: 2
Pages: 910-7
Publication
First Author: Jain N
Year: 2010
Journal: Proc Natl Acad Sci U S A
Title: Dual function of CTLA-4 in regulatory T cells and conventional T cells to prevent multiorgan autoimmunity.
Volume: 107
Issue: 4
Pages: 1524-8
Publication
First Author: Corse E
Year: 2012
Journal: J Immunol
Title: Cutting edge: CTLA-4 on effector T cells inhibits in trans.
Volume: 189
Issue: 3
Pages: 1123-7